Roche Makes Play For Bowel Disease Leadership With $7.1bn Roivant Deal

 
• By Andrew McConaghie
  
Roche
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip